Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurelien Justet

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Hypoxia-Induced Cardiopulmonary Remodeling and Recovery: Critical Roles of the Proximal Pulmonary Artery, Macrophages, and ExerciseAbhay B Ramachandra, Prapti Sharma, Ruben De Man, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2024
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity PneumonitisAmy Y Zhao, Avraham Unterman, Nebal S Abu Hussein, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular ProgramsAlan Waich, Scott A Ochsner, Julian A Villalba, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2026
Alveolar niche disruption and aberrant epithelial reprogramming are early hallmarks of idiopathic pulmonary fibrosisAurelien Justet, Venerino Poletti, Cristian Coarfa, et al.
The European Respiratory Journal|July 9, 2026
Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung TransplantationLena M Leiber, Leonard Christian, Lavinia Neubert, et al.
Nature Communications|August 2, 2025
Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical modelsDarcy Elizabeth Wagner, Hani N Alsafadi, Nilay Mitash, et al.
American Journal of Respiratory and Critical Care Medicine|August 23, 2022
Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary FibrosisFarida Ahangari, Christine Becker, Daniel G Foster, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Hypoxia-Induced Cardiopulmonary Remodeling and Recovery: Critical Roles of the Proximal Pulmonary Artery, Macrophages, and ExerciseAbhay B Ramachandra, Prapti Sharma, Ruben De Man, et al.
American Journal of Respiratory and Critical Care Medicine|June 26, 2024
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity PneumonitisAmy Y Zhao, Avraham Unterman, Nebal S Abu Hussein, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Early Pulmonary Fibrosis is Defined by Niche- and Cell-Specific Molecular ProgramsAlan Waich, Scott A Ochsner, Julian A Villalba, et al.
Biorxiv : the Preprint Server for Biology|July 2, 2026
Alveolar niche disruption and aberrant epithelial reprogramming are early hallmarks of idiopathic pulmonary fibrosisAurelien Justet, Venerino Poletti, Cristian Coarfa, et al.
The European Respiratory Journal|July 9, 2026
Aberrant and Ectopic Cell Populations in Restrictive Allograft Syndrome after Lung TransplantationLena M Leiber, Leonard Christian, Lavinia Neubert, et al.
Nature Communications|August 2, 2025
Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical modelsDarcy Elizabeth Wagner, Hani N Alsafadi, Nilay Mitash, et al.
American Journal of Respiratory and Critical Care Medicine|August 23, 2022
Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary FibrosisFarida Ahangari, Christine Becker, Daniel G Foster, et al.
Pageof 2